BGT vs ENL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

ENL

ENLITIC CDI FORUS [ENL]

36LOW

Score Breakdown

BGT ENL
Technical
48
42
Catalyst
50
60
Sentiment
50
50
Fundamental
44
37
Momentum
52
44
Risk Gate
27
19

Key Metrics

BGT Metric ENL
$6.6MMarket Cap$5.8M
754KAvg Volume (20d)4.1M
N/AShort Interest+0.1%
$0.06152-Week High$0.045
$0.01652-Week Low$0.004
+0.0%Daily Change+0.0%
$0.017Entry Price$0.007
-202.2%ROE-177.1%
N/AProfit MarginN/A

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

ENL Signals

Volume surging at 2.1x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.25, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.9 quarters)
Low P/S ratio (1.5x)
Strong revenue growth (+118%)
Piotroski F-Score weak (3/9, low-confidence approx)
Near 52-week low (6% of range)

Ask Scout AI to compare BGT and ENL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BGT Full Analysis → ENL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).